Sodium Bicarbonate → HCID 178448291, compound
Reaction equation
[Br:1][C:2]1[C:3]([NH:16][C@H:17]([CH:20]([CH3:22])[CH3:21])[CH2:18][OH:19])=[N:4][C:5]([NH:8][C:9]2[NH:13][C:12]([S:14][CH3:15])=[N:11][N:10]=2)=[N:6][CH:7]=1.C([O-])(O)=[O:24].[Na+].OOS([O-])=O.[K+]>CO.O.O>[Br:1][C:2]1[C:3]([NH:16][C@H:17]([CH:20]([CH3:22])[CH3:21])[CH2:18][OH:19])=[N:4][C:5]([NH:8][C:9]2[NH:13][C:12]([S:14]([CH3:15])=[O:24])=[N:11][N:10]=2)=[N:6][CH:7]=1Participants
Procedure
At 0° C., 159 mg (0.41 mmol) of (R)-2-[5-bromo-2-(5-methylsulfanyl-4H-[1,2,4]triazol-3-ylamino)-pyrimidin-4-ylamino]-3-methyl-butan-1-ol in 4 ml of MeOH/water (4:1) is mixed with 80 mg (0.95 mmol) of NaHCO3 and 98 mg (0.95 mmol) of oxone. The reaction mixture is stirred for 2 hours at room temperature, then another 50 mg (0.5 mmol) of oxone is added, and it is stirred for 1 hour at 30° C. The batch is diluted with water and extracted with ethyl acetate. The organic phase is concentrated by evaporation and purified by chromatography (methylene chloride-(methylene chloride/ethanol: 9/1); Flashmaster II). After the recrystallization, 45 mg (0.11 mmol, 27% of theory) of the product (R)-2-[5-bromo-2-(5-methanesulfinyl-4H-[1,2,4]triazol-3-ylamino)-pyrimidin-4-ylamino]-3-methyl-butan-1-ol is obtained.
Workup
- stirringit is stirred for 1 hour at 30° C
- extractionextracted with ethyl acetate
- concentrationThe organic phase is concentrated by evaporation
- custompurified by chromatography (methylene chloride-(methylene chloride/ethanol: 9/1); Flashmaster II)
- customAfter the recrystallization, 45 mg (0.11 mmol, 27% of theory) of the product (R)-2-[5-bromo-2-(5-methanesulfinyl-4H-[1,2,4]triazol-3-ylamino)-pyrimidin-4-ylamino]-3-methyl-butan-1-ol
- customis obtained
Sources & evidence
- ORD record
- ord-7657b7a0d67d4ba6bc1183af2e2ddd96
- Source dataset
- uspto-grants-2007_10
- Patent number
- US07288547B2
Reaction notes
Loading…